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Cell sublines were derived from Ni-induced rat rhabdomyosarcoma which differed in their degree of tumorigenicity. WC cornpaled the expression 
of protein kinase C isoforms dl, 8.7 and E in three sublines developing tumors in syngeneic rats (Sy’) and in two sublines devoid of tumorigenicity 
in these animals (Sy-), with that of normal skeletal muscle. Northern and Western blotting experiments showed that PKC a was dramatically 
overexpressed in Sy- cells whereas itwas underexpressed in Sy’cells. Southern blot analysis provided evidence for a 3.fold increase of PKC a-relatuzd 
DNA fragments in Sy- cells, Steady-state l vels of the PKC &-related transcript were also markedly decreased inSy’ cells. However, the expression 
of PKCSrelated RNA was increased in these cells. Our data support the concept hat the differential expression of the PKC isoforms may play 
a critical role in determining the neoplastic phenotype. 
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1. INTRODUCTION 
Protein kinase C (PKC) plays a key role in signal 
transduction. Extracellular ligand binding to specific 
surface receptors results in phosphoiipid breakdown 
which yields diacylglycerol, the physiological activator 
of PKC. Enzyme activation proceeds through close in. 
teractions with membranes, presumably at the sites of 
DG formation. Membrane-bound PKC becomes a sub- 
strate for calpnin-related proteases and is rapidly down- 
regulated [l-3]. Protein kinase C consists of a family of 
closely related proteins expressed in a tissue-specific 
manner. These isoforms exhibit differences in enzymatic 
characteristics (e.g. substrate specificity, stisceptibility 
to down-regulation, dependence on Ca”) which reflect 
their functional heterogeneity 14-71. As a rule, several 
isoforms are expressed in a given cell type which may 
relate to distinct signalling pathways. 
A number of tumor promoters, including phorbol 
esters, activate PKC through an interaction with the 
DG-binding site or unknown sites, and mimick the ac- 
tion of the physiological effector (as reviewed in refs. [8] 
and [9]). Phenotypic changes associated with induction 
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of differentiation have been related to alterations in the 
expression of specific PKC isoforms [lO-121. In tumors, 
activities are generally found to be impaired; they are 
either reduced or increased when compared to parent 
normal tissues [13-l 61. In addition, cDNA transfection 
and stable expression of an individual PKC isoform 
may affect growth and tumorigenicity in cell lines [17- 
191. The above data suggest that the levels of expression 
of individual PKC isoforms may contribute to specify 
the cell phenotype. 
In the present work, we examined the expression of 
PKC a, 8, y and E isoforms in skeletal muscle and 
rhabdomyosarcomaderived sublines exhibiting various 
degrees of tumorigenicity. We report severe alterations 
in the expression of these isoforms which were associ- 
ated with cancer cell phenotype. 
2. MATERIALS AND METHODS 
2.1. CeR lines and tumors 
The parental RMS 940 cell line was established inculture from a 
Ni-induced rat rhabdomyosarcoma. Cell sublines with differing tumo- 
riynicity were selected, as described in refs. [20] and [211. RMS 94-4 
S4 and F21 cell lines were tumorigenic in syngeneic rats where R9 and 
C8 cell lines were not tumorigcnic but formed tumors in nude mica. 
The present study wns prfonned on solid tumors obtained after 
injection of these sublines. Herein, we refer to the first three as Sy’ and 
the last two as Sy-. 
2.2. RNA isoLrion and Northern blot analyst3 
To%2 RNA was isolated from tumors and rat quadriceps muscle by 
the guanidiniumxesium chloride method and poly(A’)RNA was se- 
lected by retention on an ohgo cellulose column. Poly(A’)RNA 
was analyzed by electrophorcsis and Northern blot hybridizntion ac- 
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Fig. 1, Expression of PKC a, 8, B-related transcripts in muscle, in three sublines which are tumorigenic in syngeneic rats (Sy’), RMS 9-410, F2 1, 
S4 and in two sublines (C8, R9) which are non-tumorigenic n syngcneic rats (Sy-). Poly(A’) RNA were analyzed by agarose &cl electrophoresis 
and by successive hybridizations to randomized 32P-labeled PKCrr,/?, EcDNA probes (0.5-I x lO”cpm/~g DNA). Exposure timeof autoradiograms 
was, respectively, 15, 60 and 40 h for PKCo, B and E probes, RNA blots were hybridized to a GAPDH cDNA probe to assess the amounts or 
RNA present in each well. Ribosomal RNA 18s and 28s were used as size markers. 
cording to a standard procedure [22] with the appropriate probes. The 
PKC z probe was a I ,77 kb Bcr~rtHI fragment; the PKC ~5,) fi1 probe 
was a 1.22 kb PsrI fragment; he PKC y probe was a 2.1 kb BnmHI- 
X&I fragment, the PKC E probe was a 2 kb &c&I fragment; the 
GAPDH probe was a 1.3 kb PsrI fragment. 
2.3. DNA isahion and Sourhern blot anai)sis 
DNA extracted from tumors and quadriceps muscle were digested 
with 2-3 U&g DNA of EcoRI. DNA fragments were fractionated by 
eleclrophoresis on 0,7% a&arose gels according to a standard proce- 
dure [Xi. li DNA-ffi/ldlII digest was used as size marker, DNA 
fragments were transferred overnight by blotting to nitrocellolosc 
membrane, Hybridization was carried out overnight with DNA 
probes for PKC a and PKCB in theconditions used for Northern blot 
analysis. Autoradiograms were quantitated by scanning and integra- 
tion using Joyce and Loebl denshometcr, model Chromoscan 3, 
2.4. Jrtmunoblor arzu!ysis of PKC a and PKC p isoforms 
Deep frozen tumors and muscle were homogenized in 20 mM Tris 
buffer (pIi 7.4) containing IO mM EGTA, 2 mM EDTA, OS% Non- 
idet P-40, 2 mM PMSF, and 10 m&ml leupeptin. Detergent-soluble 
protein extracls were fractionated by SDS-PAGE and transferred to 
nitrocellulose membrane overnight by clectrophoretic transfer, Non- 
specific binding was blocked by incubating the blots with 10% horse 
serum containing 5% dried milk for 1 h and soaked twice for 15 min 
in 20 mM Tris-HCI buffer (pH 9.4) containing 0.5 M NaCl and 0.05% 
(v/v) Tween 20. Membranes were incubated for 2 h with 1 mgml PKC 
a-specific monoclonal antibody MC-3a [24] or polyclonol anti PKC 
~-specific aniipeptide diluted I:100 [IO]. Washed blots were then incu- 
batod for 1 h with horseradish pcroxicinse conjugated sheep nnti- 
mouse IgG (PKC a) or goat anti-rabbit IgG (PKC m diluted 1:2000. 
The blots were developed using ECL Western blotting detection 
(Amersham), Rat brain PKC, purified as previously described [25] 
migrated in parallel. 
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3. RESULTS 
Northern hybridization analysis of poly(A”) RNA 
showed striking changes in the expression of PKC OL- 
related transcripts in r-habdomyosarcoma-derived c lls 
when compared to skeletal muscle where two tran- 
scripts of 9.5 and 3.4 kb were present (Fig. 1). In Sy’ 
cells, the smaller transcript was overexpressed whereas 
both transcripts were barely detectable, even after a 
2-day exposure in Sy’ cells. PKC /3 was poorly ex- 
p:essed in muscle and tumors. However, the expression 
of the two transcripts (10.5 and 2.7 kb) was enhanced 
in Sy’ cells when compared to that in skeletal muscle 
(Fig. 1). The weak 3.4 kb band detected by the PKC ,8 
probe only in Sy- cells was likely due to a non-specific 
hybridization of this probe to the PKC 01 3.4 kb tran- 
script overexpressed in these cells. The PKC E-related 
transcript (7.0 kb) was detected in skeletal muscle. This 
transcript was less strongly expressed in rhabdomyosar- 
coma-derived cells than in muscle, and was virtually 
undetectable in Sy+ cells. PKC y was not expressed in 
any sublines. No transcript could be observed even after 
S-day exposure. 
Southern blot analysis of E’coRI-digested DNA from 
these materials showed an increased hybridization in 
Sy- cells with PKC a probe whereas PKC j3 probe hy- 
bridization was similar in all cells. Fig. 2A and B display 
the autoradiograms of major DNA fragments of 13.8 
kb and 8.5 kb detected with PKC a and PKC /? probes, 
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Fig. 2. PKC QI and PKC fi cDNA hybridization to EcoRI restricted 
DNA from muscle, Sy’ (RMS 9=4/O. F21, S4) and Sy- cells (CS, R9), 
EcoRl-restricted DNA fragments were resolved by agarose gel elecvo- 
phoresis and hybridized to randomized “P-labeled PKC tx and PKC 
B cDNA probes as described in the legend to Fig. I. The two probes 
were hybridized to the same blots which were exposed for 24 (PKC 
a) and 48 h (PKCB). A and B: major DNA fragments related to PKC 
& and PKC p of 13.8 and 8.5 kb, respectively. Autoradiograms w’ere 
scanned by densitometry and the ratio PKC aIPKCp probe hybridi- 
zation is displayed in C. 
respectively. Hybridization was quantitated by den- 
sitometric scanning and the ratio PKC cz/PKC fi sug- 
gested that the PKC cc gene is 3-fold amplified in Sy- 
cells, unless chromosomal abnormali tites are present 
(Fig. 2C). 
Immunoblotting experiments were performed in mus- 
cle, F21 and R9 cells, using antibodies raised against 
isoforms oc and /I. As a control, we used PKC purified 
from rat brain which expressed all isofonns. As shown 
in Fig. 3, Sy- cells R9 strongly expressed PKC o! while 
we failed to detect he enzyme in muscle and Sy’ cells 
F2 1. In contrast PKC ,B was expressed similarly in F2 1 
and R9 cells, while this isoform was not detectable in 
muscle. However, several muscle proteins (~10’ kDa) 
were detected with antibody raised against PKC p. 
Fig, 3. Immunoblot analysis of detergent-soluble protein extracts (ap 
proximately 100 ~6 protein) from muscle, Sy’ F21 cells, Sy- R9 cells 
and 20 ng of purified rat brain PKC with specific antibodies raised 
against PKC a (A) or PKC ,9 (B). The arrow indicates the major 
reactive species the size of which is SO kDa. 
4. DISCUSSION 
This study provides the first demonstration of a cor- 
relation between the expression of some PKC isoforms 
in a series of rat rhabdomyosarcoma-derived sublines 
and tumor ccl1 growth in syngeneic animals. Northern 
blot analysis has shown that Sy- cells which do not grow 
in syngeneic animals overexpressed PKC 01 whereas the 
expression of this isoform was decreased in Sy’ cells. 
lntcrestingly, one of us (N.H.) recently reported that 
Sy- but not Sy’ ceils, strongly expressed c-s& related 
transcripts which encode for the B-chain of PDGF [20]. 
The observed changes in the expression of PKC a and 
PKC B are consistent with the characteristics of fibro- 
blast R6 cells overproducing PKC p [ 17’j or PKC a [18]. 
Indeed, R6 cell derivatives carrying an integrated copy 
of PKC p, cDNA insert, became partially or completely 
transformed upon overproduction of PKC B,, while cell 
derivatives carrying the PKC 01 cDNA insert failed to 
grow in soft agar, though these cells strongly expressed 
PKC CL However, it should be stressed that the induc- 
tion of individual PKC isoform-specific phenotypic 
changes appears to be cell line- and/or tissue-specific, 
since overexpression of PKC p, in the colon cancer cells 
HT29 suppressed the neoplastic phenotype [19]. 
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